Clinical pharmacology insights from recent cell and gene therapy approvals relevant to pediatrics
Cell and gene therapies are rapidly transforming the pediatric rare disease treatment landscape and are offering new possibilities for conditions…
Audience: Biotech & Industry
-
-
PRACTICE Trials: Regulatory Reform to Advance Evidence-Based Pediatric Care
RareKids-CAN is committed to transforming Canada’s regulatory and clinical research environment to ensure equitable access to safe and effective therapies…